Back to search

Article

Predicting Tumor Mutational Burden from UHF-Dielectrophoresis Crossover Frequency

2024-11-06

Abstract excerpt

<h4>ABSTRACT</h4> Tumor Mutational Burden (TMB) has emerged as a crucial biomarker to guide patient eligibility for immunotherapy. However, whole exome sequencing, the gold-standard method for TMB measurement, remains limited in accessibility due to its high costs, operational complexity, and lengthy processing times. To address these limitations, we investigated whether Ultra-High-Frequency (UHF) technology coul...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8df5de51-ed93-5c87-b985-88977ab9c669
DOI
10.1101/2024.11.05.622085
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predicting Tumor Mutational Burden from UHF-Dielectrophoresis Crossover FrequencyDOI 10.1101/2024.11.05.622085
Select a neighboring publication to make it the new centre.